Semaglutide GLP-1 reduces hunger and cravings by affecting the area of the brain responsible for regulating appetite
This means supplement manufacturers do not need FDA approval before selling their products
Injectable Dose: 0.1 to 0.2 mg three times weekly Topical Option: Apply serum to target areas twice daily Combined Approach: Injectable 3x weekly plus topical to specific areas Duration: 8 to 12 weeks, can extend longer due to favorable safety profile The timing of GHK-Cu introduction matters for maximum benefit
Abusukhun M, Winkler MS, Phlmann S, Moerer O, Meissner K, Tampe B, et al
Early-access pricing reserved for waitlist members only, kept lower than open-market rates
GHK-Cu for Hair Growth and Follicle Health Hair loss affects millions of Canadians, and the available treatments come with notable limitations